A new study on cannabidiol (CBD) products across the country has shown that a considerable amount of the available products would have problems with the legal cannabis potency regulations. The study found that around 27% of the products had differences in their ‘potency vs potency claims’ and it found that those same products would not pass the standard for products permitted to be sold.
Leafreport partnered up with Las Vegas’ Canalysis Laboratories in order to check whether CBD products contain as much as they claim to. The results displayed that 10 out of 37 products did not contain as much CBD as they have stated.
The researchers rated the CBD stated on the label against that measured by technicians from Canalysis Laboratories. The cannabis industry experts agree that 10% invariance is an acceptable amount and that good-quality CBD products are expected to contain 90-110% of what is stated on the label.
The study also found that the products which tested best were from popular and reputable brands as opposed to the lesser-known companies which performed more poorly. Fortunately, most of the products will likely contain more CBD than what is advertised.
Lazarus Naturals, CBDistillery, cbdMD, CBDfx, and Green Roads are some of the brands which yielded the best results. These brands also provide the accuracy and transparency of their products and their company.
“Actually, when we conducted the study, we expected to see worse results. We thought we would see a lot of products that have a larger variance than 10 percent, which is the acceptable variance. Most of the products really had an acceptable variance, except for ten. So for us, we find that the market has matured and that brands really do take care to be conscious of the CBD in their products” said Leafreport.
Despite yielding dominantly promising results, having 27% of the products with unacceptable variances is still cause for concern. Especially if the consumer is new to the market, or has a limited knowledge base on cannabis brands and products.
The cannabis industry is notorious for its lack of transparency which is why Leafreport is on a mission to change that and to educate cannabis consumers. The CBD industry has already come a long way in terms of the quality and quantities of cannabinoids in the products. Many brands have even taken to sending their products for third-party testing in order to assure their quality and accuracy.
Third-party lab tests are performed by unaffiliated and independent laboratories, which provide objectivity. These tests are important for confirming the potency, accuracy, and safety of the product being tested. The most common and important tests done on CBD products include a cannabinoid profile test and a potency test. These tests will identify how much of what cannabinoid is in the plant in comparison to the label.
These tests are important because a product with less CBD than claimed is likely to be less effective, a product containing too much more could bring on unwanted effects and these tests help make sure that consumers are getting their money’s worth.
Many Americans wrongly believe that the CBD in products is regulated by the FDA. At this point in time, the FDA still needs to produce the manner in which they will regulate CBD businesses and the FDA has only approved Epidiolex thus far. The FDA wants research to be done in order for them to approve more cannabis-derived products.
Therefore, it is strongly recommended that you stick to buying from reputable CBD brands, in order to assure the quality and accuracy of the product you’re purchasing. Leafreport also urges consumers not to be seduced by lower prices from unknown or new brands. It is for your benefit to rather pay a little extra for quality and accuracy.
“Do you prefer an indica or a sativa?” is typically the first question asked at a dispensary. Indica vs. sativa refers to the two main categories of cannabis strains. Both indicas and sativas differ in appearance and effects. Indicas are generally known for a sedating effect, while sativa strains are known for a cerebral high….
According to research, “Migraine is highly prevalent, affecting 12% of the population, attacking up to 17% of women and 6% of men yearly. Among children, it tends to happen more in girls than boys.” A migraine can be very disabling and last from hours to two or three days. Migraines are considered to be the…
PTSD can have far-reaching effects on health, functionality as well as on quality of living, which is why having access to effective treatment is so important. If you are living with PTSD or are living with someone who has PTSD, you would have first-hand experience with how challenging it can be getting through life on…
Up until recently, lack of cannabis education meant that people were blissfully unaware of the fact that the plant is not limited to just one strain and, therefore, does not produce just one type of effect. Fortunately, agricultural experimentation has led to the market exploding in terms of strains that can satisfy everyone, from beginners…
Using cannabis to help combat anxiety is a tricky business. Studies have given us significant evidence that cannabis can be used to help cope with anxiety and because anxiety is so common, that’s an extremely welcome piece of information. In fact, 72% of daily cannabis users reported consumption to relax or relieve tension and 58%…
Side hustle: Many of us have one (or more) to help make some extra for things we need and want in life—things…
Ohio introduced a legalization bill, cannabis and psilocybin could be the future of cancer care, and a ketamine company is looking to…
A bill was passed to legalize the possession and sharing of certain psychedelics for Californians aged 21 and above. The bill underwent…